EPAS1 and breast neoplasm: Extending our murine breast tumor model (>28 days/2 cm), we found a significant reduction in tumor macrophages in myeloid HIF-2α-deficient mice compared to controls, suggesting that reduced TAMs from myeloid HIF-2α deficiency may span several tumor types but the length of tumor progression matters (results in preparation for publication).